AI assistant
CYTOKINETICS INC — Director's Dealing 2013
Mar 7, 2013
30870_dirs_2013-03-07_426b8977-5ac7-42d5-bb7c-62bea0544155.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2013-03-05
Reporting Person: Malik Fady Ibraham (SVP Research & Early Dev)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-03-05 | Incentive Stock Option (right to buy) | $1 | A | 161112 | Acquired | 2023-03-05 | Common Stock (161112) | Direct |
| 2013-03-05 | Non-Qualified Stock Option (right to buy) | $1 | A | 138888 | Acquired | 2023-03-05 | Common Stock (138888) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 90330 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $1.05 | 2022-03-05 | Common Stock (136434) | 136434 | Direct |
| Incentive Stock Option (right to buy) | $1.57 | 2021-02-28 | Common Stock (71298) | 71298 | Direct |
| Incentive Stock Option (right to buy) | $1.85 | 2019-02-26 | Common Stock (31669) | 31669 | Direct |
| Incentive Stock Option (right to buy) | $3.08 | 2020-02-24 | Common Stock (44954) | 44954 | Direct |
| Incentive Stock Option (right to buy) | $3.37 | 2018-02-28 | Common Stock (10395) | 10395 | Direct |
| Incentive Stock Option (right to buy) | $6.5 | 2014-03-04 | Common Stock (12500) | 12500 | Direct |
| Incentive Stock Option (right to buy) | $6.81 | 2017-03-14 | Common Stock (17722) | 17722 | Direct |
| Incentive Stock Option (right to buy) | $7.04 | 2016-03-15 | Common Stock (35000) | 35000 | Direct |
| Incentive Stock Option (right to buy) | $7.1 | 2015-03-23 | Common Stock (9000) | 9000 | Direct |
| Non-Qualified Stock Option (right to buy) | $1.05 | 2022-03-05 | Common Stock (38566) | 38566 | Direct |
| Non-Qualified Stock Option (right to buy) | $1.57 | 2021-02-28 | Common Stock (3702) | 3702 | Direct |
| Non-Qualified Stock Option (right to buy) | $1.85 | 2019-02-26 | Common Stock (8331) | 8331 | Direct |
| Non-Qualified Stock Option (right to buy) | $3.08 | 2020-02-24 | Common Stock (5046) | 5046 | Direct |
| Non-Qualified Stock Option (right to buy) | $3.37 | 2018-02-28 | Common Stock (8415) | 8415 | Direct |
| Non-Qualified Stock Option (right to buy) | $6.81 | 2017-03-14 | Common Stock (2078) | 2078 | Direct |
| Restricted Stock Units | $ | Common Stock (87500) | 87500 | Direct |
Footnotes
F1: When the ISO and NQ dated 03/05/2013 are combined for a total grant of 300,000 shares, the option shall vest and become exercisable as to 300,000 shares divided into equal monthly installments such that the option shall be 100% vested on 03/05/2017.
F2: When the ISO and NQ dated 03/05/2012 are combined for a total grant of 175,000 shares, the option shall vest and become exercisable as to 3,645 shares on 04/05/2012 and the balance of 171,355 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/05/2016.
F3: When the ISO and NQ dated 02/28/2011 are combined for a total grant of 75,000 shares, the option shall vest and become exercisable as to 1,562 shares on 03/31/2011 and the balance of 73,438 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/28/2015.
F4: When the ISO and NQ dated 02/26/2009 are combined for a total grant of 40,000 shares, the option shall vest and become exercisable as to 833 shares on 03/26/09 and the balance of 39,167 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/26/13.
F5: When the ISO and NQ dated 02/24/2010 are combined for a total grant of 50,000 shares, the option shall vest and become exercisable as to 1,041 shares on 03/24/2010 and the balance of 48,959 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/24/2014.
F6: When the ISO and NQ dated 02/29/2008 are combined for a total grant of 18,810 shares, the option shall vest and become exercisable as to 391 shares on 03/29/08 and the balance of 18,419 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/29/12.
F7: This option is immediately exercisable upon grant and shall vest as to 260 shares on 04/01/04 and the balance of 12,240 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/08.
F8: When the ISO and NQ dated 03/14/2007 are combined for a total grant of 19,800 shares, the option shall vest and become exercisable as to 412 shares on 04/01/07 and the balance of 19,388 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/11.
F9: This option shall vest and become exercisable as to 729 shares on 04/01/06 and the balance of 34,271 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/10.
F10: This option shall vest and become exercisable as to 187 shares on 04/01/05 and the balance of 8,813 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/09.
F11: Each restricted stock unit represents a contingent right to receive one share of CYTK common stock at a purchase price of $0.001 per share which is the current par value of the common stock.
F12: The restricted stock units vest in two equal annual installments. Vested shares will be delivered to the reporting person on 9/4/2012 and 9/3/2013.